Your Search for 'Snapshots Ireland Pharmaceuticals 2009' returned 9 results - Page 1 of 1

• Angiogenesis Inhibitors and Stimulators - Global Business Strategic Report

  EURO€ 4,381.00USD$ 4,950.00GBP£ 2,920.00AUD$ 6,845.00JPY¥ 593,598.00SEK 38 940,00CHF 6'519.00CAD$ 6,349.00 Global Industry Analysts, Inc, May 2012 , Pages: 675
  Product Segments: Angiogenesis Inhibitors, and Angiogenesis Stimulators. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for ...

• CNS Therapeutics - Global Strategic Business Report

  EURO€ 4,381.00USD$ 4,950.00GBP£ 2,920.00AUD$ 6,845.00JPY¥ 593,598.00SEK 38 940,00CHF 6'519.00CAD$ 6,349.00 Global Industry Analysts, Inc, Feb 2013 , Pages: 1058
  PLAYERS II-113 AbbVie Inc (USA) II-113 Alkermes Plc (Ireland) II-113 Amneal Pharmaceuticals, LLC (USA) II-114 Aspen Pharmacare Holdings Limited (South Africa) II-115 AstraZeneca Plc (UK) II-115 BEACON ...

• Vitamins - Global Strategic Business Report

  EURO€ 3,982.00USD$ 4,500.00GBP£ 2,655.00AUD$ 6,223.00JPY¥ 539,634.00SEK 35 400,00CHF 5'926.00CAD$ 5,772.00 Global Industry Analysts, Inc, Oct 2011 , Pages: 977
  Complex, Vitamin C, and Other Vitamins (Vitamin K, Carotenoids and others). Specific end-use segments also analyzed are Animal Feed Additives, Cosmetics, Food, and Pharmaceuticals. The report provides ...

• Osteoporosis Therapeutics - Global Business Strategic Report

  EURO€ 3,982.00USD$ 4,500.00GBP£ 2,655.00AUD$ 6,223.00JPY¥ 539,634.00SEK 35 400,00CHF 5'926.00CAD$ 5,772.00 Global Industry Analysts, Inc, May 2012 , Pages: 455
  for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 49 companies including many key and niche players such as Abbott Laboratories, Eli ...

• Animal Feed Additives - Global Strategic Business Report

  EURO€ 3,982.00USD$ 4,500.00GBP£ 2,655.00AUD$ 6,223.00JPY¥ 539,634.00SEK 35 400,00CHF 5'926.00CAD$ 5,772.00 Global Industry Analysts, Inc, Oct 2012 , Pages: 762
  to Commence Marketing Cactus Hog Feed II-41 Ganeden Biotech Announces Introduction of GanPro™ II-41 7. RECENT INDUSTRY ACTIVITY II-42 Dechra Pharmaceuticals Takes Over Eurovet Animal Health II-42 ...

• Packaging Machinery - Global Strategic Business Report

  EURO€ 3,982.00USD$ 4,500.00GBP£ 2,655.00AUD$ 6,223.00JPY¥ 539,634.00SEK 35 400,00CHF 5'926.00CAD$ 5,772.00 Global Industry Analysts, Inc, Oct 2012 , Pages: 1204
  fastest growth rate of 8.9% over the analysis period. Bio-technology based drugs, aseptic requirements for filling liquid pharmaceuticals and the growing preference for drugs in unit-doses among healthcare ...

• Water Treatment Equipment and Supplies - Global Strategic Business Report

  EURO€ 4,381.00USD$ 4,950.00GBP£ 2,920.00AUD$ 6,845.00JPY¥ 593,598.00SEK 38 940,00CHF 6'519.00CAD$ 6,349.00 Global Industry Analysts, Inc, Nov 2012 , Pages: 870
  Domestic/ Household (includes corresponding Graph/Chart) II-3 Global Water Supply & Demand Scenario II-4 Snapshots II-4 Key Statistics II-5 Table 2: Internal Water Resource Per Capita Ranked by Region ...

• Agricultural Biotechnology - Global Strategic Business Report

  EURO€ 4,381.00USD$ 4,950.00GBP£ 2,920.00AUD$ 6,845.00JPY¥ 593,598.00SEK 38 940,00CHF 6'519.00CAD$ 6,349.00 Global Industry Analysts, Inc, Oct 2012 , Pages: 387
  Opportunity Indicators in a Nutshell II-2 Market Snapshots II-3 Barriers to Expansion of Biotechnology ...

• Protein Ingredients - Global Strategic Business Report

  EURO€ 4,381.00USD$ 4,950.00GBP£ 2,920.00AUD$ 6,845.00JPY¥ 593,598.00SEK 38 940,00CHF 6'519.00CAD$ 6,349.00 Global Industry Analysts, Inc, Oct 2012 , Pages: 503
  Snapshots II-1 Value Added Milk Products Grow at Healthy Rates II-2 Recession Adversely Impacts Milk Prices II-2 Rising Protein Consumption in Developing Economies Bodes Well for Egg Market II-3 Table 1 ...